medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2018-12-182-184medsovet-2585Research ArticleДИССЕРТАНТDISSERTANTКомплексная оценка больных хронической обструктивной болезнью легких с помощью многокомпонентного индекса ADO и индекса коморбидности CharlsonComprehensive assessment of patients with chronic obstructive pulmonary disease by means of multicomponent ADO index and Charlson comorbidity indexКочетоваЕ. В.KochetovaE.

к.м.н.

ФГБОУ ВО «Петрозаводский государственный университет»Россия201829072018012182184Copyright © Кочетова Е.В., 20182018Кочетова Е.В.Kochetova E.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/2585

Целью настоящего исследования было изучение индекса ADO и индекса коморбидности Charlson у больных хронической обструктивной болезнью легких (ХОБЛ). Материал и методы: обследованы 207 больных ХОБЛ с длительным стажем курения. Исследование ФВД проводили на многомодульной установке типа MasterLab/Jaeger. У больных определяли индексы ADO и Charlson. Результаты: показатели индекса ADO возрастали по мере усугубления стадии ХОБЛ. Минимальный уровень индекса ADO наблюдался у пациентов с ХОБЛ 2-й стадии – 2,23 ± 0,88. При 3-й стадии ХОБЛ ADO составлял 5,05 ± 1,19, при 4-й стадии ХОБЛ – 7,0 ± 1,0. Установлена корреляционная связь между индексом ADO и индексом коморбидности Charlson – r 0,7, p < 0,005. Выявлена корреляционная связь между индексом ADO и ЖЕЛ – r -0,57, p < 0,05; между индексом ADO и ERV – r -0,63, p < 0,05.

 

The purpose of this study was to investigate the ADO index, and index of comorbidity of Charlson in patients with chronic obstructive pulmonary disease (COPD). Materials and methods: 207 patients with chronic obstructive pulmonary disease (COPD) were observed. The investigated group was made by the patients having the long experience of smoking. Research of function of external breath was studied with multimodular installation of type «Master-Lab/Jaeger». Patients were determined the index ADO and of comorbidity of Charlson. Results: The index ADO increased with stage of COPD, minimum of level ADO was observed in patients with COPD 2 stage 2,23 ± 0,88, in patients with 3 stage COPD ADO was 5,05 ± 1,19, 4 stages of COPD 7,0 ± 1,0. The correlation coefficient between ADO index and and index of comorbidity Charlson was -0,71, p <0,005. The correlation coefficient between ADO and VC was -0,57, p <0,05, between ADO and ERV was -0,63, p <0,05.

 

ХОБЛиндекс ADOиндекс коморбидности CharlsonCOPDthe index ADOthe index of comorbidity CharlsonReferencesКарнаушкина М.А., Федосенко С.В., Сазонов А.Э., Петров В.А., Ваколюк Р.М., Дворецкий Л.И., Огородова Л.М. Сложности прогнозирования течения ХОБЛ как вызов современной клинической пульмонологии. Архив внутренней медицины, 2016, 4: 14-20Karnaushkina MA, Fedosenko SV, Sazonov AE, Petrov VA, Vakolyuk RM, Dvoretsky LI, Ogorodova LM. The diffi culties of predicting the course of COPD as a challenge to modern clinical pulmonology. Arkhiv Vnutrennei Meditsiny, 2016, 4: 14-20.Nishimura M, Makita H, Nagai K et al. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2012, 185: 44-52.Nishimura M, Makita H, Nagai K et al. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2012, 185: 44-52.Horita N, Koblizek V, Plutinsky M et al. Chronic obstructive pulmonary disease prognostic score: A new index. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2016 Jun, 160(2): 211-218.Horita N, Koblizek V, Plutinsky M et al. Chronic obstructive pulmonary disease prognostic score: A new index. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2016 Jun, 160(2): 211-218.O’Donnell DE. Dynamic lung hyperinfl ation and its clinical implication in COPD. Rev Mal Respir, 2009, 26: 19-29.O’Donnell DE. Dynamic lung hyperinfl ation and its clinical implication in COPD. Rev Mal Respir, 2009, 26: 19-29.O’Donnell DE. Hyperinfl ation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. Proc Am Thorac Soc, 2006, 3: 180-184.O’Donnell DE. Hyperinfl ation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. Proc Am Thorac Soc, 2006, 3: 180-184.Gatta D, Aliprandi G, Pini L, Zanardini A, Fredi M, Tantucci C. Dynamic pulmonary hyperinfl ation and low grade systemic infl ammation in stable COPD patients. Eur Rev Med Pharmacol Sci, 2011 Sep, 15(9): 1068-1073.Gatta D, Aliprandi G, Pini L, Zanardini A, Fredi M, Tantucci C. Dynamic pulmonary hyperinfl ation and low grade systemic infl ammation in stable COPD patients. Eur Rev Med Pharmacol Sci, 2011 Sep, 15(9): 1068-1073.Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis, 1987, 40: 373-383.Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis, 1987, 40: 373-383.

The authors declare that there are no conflicts of interest present.